- Home
- PGEN
PGEN
Precigen Inc.
as 11-21-2024 11:37am EST
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Upcoming Earnings Alert:
Get ready for potential market movements as Precigen Inc. PGEN prepares to release earnings report on 26 Nov 2024.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | GERMANTOWN |
| Market Cap: | 292.6M | IPO Year: | N/A |
| Target Price: | $7.00 | AVG Volume (30 days): | 840.0K |
| Analyst Decision: | Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.54 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.78 - $1.93 | Next Earning Date: | 11-26-2024 |
| Revenue: | $3,963,000 | Revenue Growth: | -41.38% |
| Revenue Growth (this year): | -32.9% | Revenue Growth (next year): | 211.35% |
Latest Precigen Inc. News
PGEN Breaking Stock News: Dive into PGEN Ticker-Specific Updates for Smart Investing
Simply Wall St.
a day ago
Precigen (NASDAQ:PGEN shareholders incur further losses as stock declines 13% this week, taking five-year losses to 86%
PR Newswire
7 days ago
Precigen Reports Third Quarter 2024 Financial Results and Business Updates
PR Newswire
9 days ago
Precigen to Participate in the Stifel 2024 Healthcare Conference
Simply Wall St.
a month ago
High Growth Tech Stocks To Watch In October 2024
PR Newswire
2 months ago
Precigen to Participate in the 2024 Cantor Global Healthcare Conference
Simply Wall St.
2 months ago
While institutions own 26% of Precigen, Inc. (NASDAQ:PGEN), private equity firms are its largest shareholders with 43% ownership
Simply Wall St.
3 months ago
Precigen Second Quarter 2024 Earnings: Misses Expectations
PR Newswire
3 months ago
Precigen Reports Second Quarter and First Half 2024 Financial Results and Business Updates
Compare PGEN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PGEN Precigen Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.